Dermatology
Dermatology
Advertisement
Rebecca AraujoAllergy | July 15, 2024
Cesarean section delivery was associated with an increased risk of asthma and food allergies.
Read More
Cailin ConnerChronic Spontaneous Urticaria | July 10, 2024
Patients with chronic inducible urticaria respond well to antihistamines and omalizumab.
Cailin ConnerChronic Spontaneous Urticaria | July 9, 2024
A Danish cohort study found that individuals diagnosed with urticaria had a significantly increased risk of cancer.
Cailin ConnerChronic Spontaneous Urticaria | July 8, 2024
Higher neutrophil-lymphocyte ratio and systemic immune-inflammation index may indicate the transition from acute to CU.
Rebecca AraujoAllergy | July 8, 2024
Diuretic drugs and calcium channel blockers were found to have the largest effect size.
Rebecca AraujoAllergy | July 4, 2024
Adults with atopic dermatitis had more severe insomnia and higher stress levels than matched controls.
Cailin ConnerChronic Spontaneous Urticaria | June 9, 2024
According to a recent study, omalizumab treatment in patients with CSU significantly alters cytokine levels.
Cailin ConnerChronic Spontaneous Urticaria | June 8, 2024
Approximately two-thirds of patients with CSU eligible for omalizumab prescriptions were not receiving them.
Cailin ConnerChronic Spontaneous Urticaria | June 7, 2024
Successful withdrawal of omalizumab was achieved in approximately 49.5% of patients with severe CSU.
Docwire News EditorsDermatology | May 20, 2024
Henry McMillan talks the engagement of dermatologists, allergists, and APPs in training over new dermatologic treatments.
Cailin ConnerChronic Spontaneous Urticaria | May 7, 2024
A study identified the potential of 2 biomarkers for monitoring disease activity and response in children with urticaria.
Cailin ConnerChronic Spontaneous Urticaria | May 7, 2024
Nearly one-third of patients with chronic spontaneous urticaria experience non-skin-related symptoms.
Lou PorteroDermatology | April 30, 2024
less than 60% of US patients with chronic inflammatory disease (CISD) receive the requisite testing
Rebecca AraujoPublic Health | April 24, 2024
The majority of children and adolescents with chronic skin conditions reported experiencing stigma.
Cailin ConnerChronic Spontaneous Urticaria | April 23, 2024
C5a, IL-9, and apo A-IV were identified as potential biomarkers for predicting CSU severity.
Cailin ConnerChronic Spontaneous Urticaria | April 23, 2024
Autologous serum skin test positivity was associated with a delayed response to omalizumab treatment in patients with CSU.
Cailin ConnerChronic Spontaneous Urticaria | April 22, 2024
A study highlighted the underutilization of patient-reported outcome measures in the management of AD and CU.
Cailin ConnerChronic Spontaneous Urticaria | April 27, 2024
Disparities in access to omalizumab for patients with CSU significantly impact treatment patterns and health outcomes.
Cailin ConnerChronic Spontaneous Urticaria | April 22, 2024
CSU negatively affects quality of life, and patients with CSU are more likely to have worse sleep.
Lou PorteroEczema | March 25, 2024
Children whose eczema began before 4 months had more food allergies than those whose eczema began after 12 months.
Advertisement
Advertisement
Advertisement
Latest News

July 26, 2024